Search clinical trials for: Ultra-Rapid Lispro

Total 1655 results

Eli Lilly and Company

Completed

A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)

Diabetes Type 1

United States, Spain
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 Formulations in Healthy Participants

Healthy Volunteers

Singapore
Eli Lilly and Company

Completed

A Study of Various Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of a New LY900014 Formulation in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Canada, Germany
Eli Lilly and Company

Completed

A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Japan
Eli Lilly and Company

Completed

A Study of LY900014 Formulation in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 in Healthy Chinese Participants

Healthy

China
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Study to Compare 2 Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants

Diabetes Mellitus, Type 2

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 in a Medtronic Pump

Type1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

Healthy

Japan
Eli Lilly and Company

Completed

Study to Compare 2 Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy (PRONTO-Pump-2)

Type 1 Diabetes Mellitus

Spain, United States, France, Israel, Australia, Germany, Italy, Puerto Rico, Austria, Hungary, Canada
Perosphere Pharmaceuticals Inc, a wholly owned...
Profil Institut für Stoffwechselforschung GmbH

Withdrawn

Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes (PRONTO-T1D)

Type 1 Diabetes Mellitus

Italy, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
Michael Tsoukas
Adocia

Recruiting

Safety and Efficacy of BC LisPram

Type1 Diabetes Mellitus

Canada
University of Cambridge

Completed

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)

Type 1 Diabetes

United Kingdom
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus

China, Argentina, Mexico
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus

China, Mexico, Argentina
Eli Lilly and Company

Completed

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes (PRONTO-Peds)

Type 1 Diabetes Mellitus

United States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
IHU Strasbourg

Terminated

Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images (BiliFast)

Cholangiocarcinoma | Pancreatitis | Cholangitis | Pancreatic Ductal Adenocarcinoma | Gallstone

France
Eli Lilly and Company

Completed

A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PRONTO-T2D)

Type 2 Diabetes Mellitus

United States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
Wockhardt

Withdrawn

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects

Bioequivalence in Healthy Subjects

United States
Centre Georges Francois Leclerc

Not yet recruiting

Use of an Ultra-rapid BRCA1/2 Status Screening Test in Theranostic Indication: Performance and Interest for Patients and Practitioners (TURBO)

Breast Cancer
New York State Psychiatric Institute

Completed

Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS) (TMS)

Depersonalization Disorder

United States
Wayne State University
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Adaptation to Prevent Drug Use (RAPD)

Substance Use

United States
Stanford University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Evaluating the Benefits of Physiologic Insulin Delivery

Type 1 Diabetes

United States
Northumbria University
Diabetes UK

Completed

Post-exercise Insulin Reductions in Type 1 Diabetes

Type 1 Diabetes

United Kingdom
New York State Psychiatric Institute

Completed

Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); National Alliance for Research...

Terminated

Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)

Schizophrenia | Schizoaffective Disorder

United States
Haukeland University Hospital
Rigshospitalet, Denmark; University of Copenhagen; University of Bergen; UMC Utrecht and other collaborators

Terminated

Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP (CAPNOR)

Pneumonia

Norway
New York State Psychiatric Institute

Completed

Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression (rTMS)

Major Depressive Disorder | Panic Disorder

United States
Wockhardt

Withdrawn

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects

Bioequivalence in Healthy Subjects

United States
Hadassah Medical Organization

Unknown

Cystic Fibrosis (CF) Exacerbation and Insulin Treatment

Cystic Fibrosis | Impaired Glucose Tolerance | Pulmonary Exacerbation

Israel
Oncology Institute of Vojvodina

Recruiting

Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI)

Breast Cancer Female

Serbia
Diasome Pharmaceuticlas, Inc.

Recruiting

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec (OPTI-2)

Diabetes Mellitus, Type 1

United States
New York State Psychiatric Institute
City University of New York, School of Public Health

Withdrawn

Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)

Depersonalization Disorder

United States
Adocia

Completed

A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

Healthy

Germany

Search clinical trials for: Ultra-Rapid Lispro

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations